Manol Jovani, MD
Gastroenterology · Miami, FLNPI 1144794496
Payments from drug & device makers
Across 62 payments — averaging $309.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pentax Of America, Inc.$16K
- Olympus Corporation Of The Americas$2K
- Boston Scientific$708
- Medtronic$368
- Creo Medical Inc.$337
- AbbVie$158
- plus $439 from 6 others
What the payments were for
- Consulting fees$6,50034%
- Travel & lodging$10,56055%
- Food & beverage$2,09211%
- Entertainment$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pentax Of America, Inc. | 19 | $15,507 |
| Olympus Corporation Of The Americas | 17 | $1,647 |
| Boston Scientific | 10 | $708 |
| Medtronic | 4 | $368 |
| Creo Medical Inc. | 1 | $337 |
| AbbVie | 3 | $158 |
| Olympus America Inc. | 2 | $135 |
| Intra-sana Laboratories | 2 | $105 |
| Fujifilm Healthcare Americas Corporation | 1 | $85 |
| Cook Medical LLC | 1 | $73 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Micro-tech Endoscopy USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Single Use Electrosurgical Knife KD-655$1,282
- Single Use Electrosurgical Hemostatic Forceps$899
- VISIGLIDE$384
- DISPOSABLE DISTAL ATTACHMENT$384
- Olympus$384
- SPEEDBOAT$337
- DRAGONFLY PANCREATICOBILIARY SCOPE AND INSTRUMENT CHANNEL CAPS$209
- SPYGLASS$165
- APOLLO ESG System$150
- EVIS EXERA III VIDEO SYSTEM CENTER$131
- Skyrizi$124
How this compares
$19,165 in reported general payments places this provider in the 80th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dicyclomine Hcl | 11 | $220 |
| Pantoprazole Sodium | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Miami
- Zaid RanaMiami$5.4M
- Angel VentoMiami$2.5M
- Francisco Bautista-MenaMiami$2M
- Miguel RodriguezMiami$2M
- Frances Robles-PenaMiami$1.7M
- Javier SobradoMiami$1.4M
- David KermanMiami$1.4M
- Lukasz KwapiszMiami$1.3M
- Oriana DamasMiami$903K
- David GoldbergMiami$858K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.